ストックスクリーナーアプリを入手
2.11
2.93%
0.06
アフターアワーズ：
2.14
0.03
+1.42%
前日終値:
$2.05
開ける：
$2.03
24時間の取引高:
59,713
Relative Volume:
0.97
時価総額：
$24.42M
収益：
$3.02M
当期純損益:
$-653.00K
株価収益率:
-42.80
EPS:
-0.0493
ネットキャッシュフロー:
$2.42M
1週間 パフォーマンス:
+4.46%
1か月 パフォーマンス:
-2.76%
6か月 パフォーマンス:
+102.88%
1年 パフォーマンス:
+104.85%
1日の値動き範囲:
$2.03
$2.22
1週間の範囲:
$1.97
$2.22
52週間の値動き範囲:
$0.9252
$2.95
Therapeuticsmd Inc Stock (TXMD) Company Profile
名前
Therapeuticsmd Inc
セクター
電話
561-961-1900
住所
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
2.11 | 23.96M | 3.02M | -653.00K | 2.42M | -0.0493 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-08-07 | ダウングレード | Jefferies | Hold → Underperform |
| 2020-05-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 開始されました | Guggenheim | Buy |
| 2019-10-17 | 開始されました | H.C. Wainwright | Buy |
| 2019-04-30 | 再開されました | Noble Capital Markets | Outperform |
| 2018-06-15 | 開始されました | JP Morgan | Overweight |
| 2017-09-08 | 開始されました | Morgan Stanley | Equal-Weight |
| 2017-07-11 | アップグレード | Oppenheimer | Perform → Outperform |
| 2017-05-09 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 再開されました | Jefferies | Buy |
| 2016-11-22 | 開始されました | Oppenheimer | Outperform |
| 2016-11-07 | 再開されました | Guggenheim | Buy |
| 2016-04-04 | 開始されました | Goldman | Buy |
| 2015-12-08 | 繰り返されました | Jefferies | Buy |
| 2015-12-08 | 繰り返されました | Stifel | Buy |
| 2015-09-21 | 繰り返されました | Jefferies | Buy |
| 2015-06-09 | 開始されました | Guggenheim | Buy |
| 2014-07-08 | 開始されました | FBR Capital | Outperform |
| 2014-04-17 | 繰り返されました | Noble Financial | Buy |
| 2014-01-28 | 繰り返されました | Noble Financial | Buy |
すべてを表示
Therapeuticsmd Inc (TXMD) 最新ニュース
Form 10-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]: [Amend] - ADVFN
TXMD Should I Buy - Intellectia AI
Total debt per share of TherapeuticsMD, Inc. – MUN:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. stock rises Wednesday, still underperforms market - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
[SCHEDULE 13G] TherapeuticsMD, Inc. Passive Investment Disclosure (>5%) - Stock Titan
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
Profit Recap: Is TherapeuticsMD Inc stock a buy or sell2026 Review & Real-Time Volume Trigger Notifications - baoquankhu1.vn
TherapeuticsMD Inc. (TXMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
TherapeuticsMD Inc. R (29TA.F) stock price, news, quote and history - Yahoo Finance UK
TherapeuticsMD Explains Brief Delay In Annual Filing - The Globe and Mail
TherapeuticsMD 2025 Annual Report: Business Overview, Risk Factors, and Intellectual Property Challenges - Minichart
[10-K/A] TherapeuticsMD, Inc. Amends Annual Report - Stock Titan
TherapeuticsMD Inc. stock rises Tuesday, still underperforms market - MarketWatch
TherapeuticsMD, Inc. (TXMD) stock price, news, quote and history - Yahoo Finance UK
TherapeuticsMD Announces Full Year 2025 Financial Results - BioSpace
TherapeuticsMD (NASDAQ: TXMD) files 2025 Form 10-K after printer error - Stock Titan
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy - TipRanks
TXMD Reports $7.5 Million in Cash Holdings as of Year-End 2025 - GuruFocus
TXMD: Net loss narrowed and license revenue surged as strategic alternatives are explored - TradingView
TXMD: 2025 saw improved results from royalty revenue, but litigation and liquidity risks threaten viability - TradingView — Track All Markets
TherapeuticsMD (NASDAQ: TXMD) reports 2025 results, weighs strategic options - Stock Titan
[10-K] TherapeuticsMD, Inc. Files Annual Report - Stock Titan
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TXMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
TherapeuticsMD, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Lumentum Holdings Leads Six-Month Stock Performance with 425.03% Return - Markets Mojo
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
Insider Trends: Whats next for TherapeuticsMD Inc stockQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Market Overview: Whats next for TherapeuticsMD Inc stockEarnings Growth Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
Lumentum Holdings Leads Stock Performance with 311.87% Return in Six Months - Markets Mojo
If You Invested $1,000 in Therapeuticsmd Inc (TXMD) - Stock Titan
Investment Report: Is TherapeuticsMD Inc forming a double bottom2026 Winners & Losers & High Conviction Buy Zone Alerts - baoquankhu1.vn
Breakout Move: Is TherapeuticsMD Inc stock a falling knife or bargain buy2025 Analyst Calls & Smart Investment Allocation Tips - baoquankhu1.vn
TXMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volatility Watch: Is TherapeuticsMD Inc stock heavily shortedJuly 2025 Intraday Action & Stepwise Swing Trade Plans - baoquankhu1.vn
TXMD PE Ratio & Valuation, Is TXMD Overvalued - Intellectia AI
Should I hold or sell BTC Digital Ltd nowEarnings Overview Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Is TherapeuticsMD Inc. forming a double bottom2025 Key Lessons & Weekly Momentum Picks - mfd.ru
What are analysts’ price targets for TherapeuticsMD Inc.Market Trend Report & Fast Exit and Entry Strategy Plans - mfd.ru
Is TherapeuticsMD Inc. stock a buy or sell2025 Retail Activity & Daily Profit Maximizing Trade Tips - mfd.ru
Aug Breakouts: Can JetAI Inc be the next market leaderWeekly Gains Report & Risk Managed Investment Signals - baoquankhu1.vn
Should you buy the dip on TherapeuticsMD Inc.Dividend Hike & Daily Momentum Trading Reports - mfd.ru
Why TherapeuticsMD Inc. stock could rally in 2025Breakout Watch & High Conviction Investment Ideas - bollywoodhelpline.com
Momentum Shift: Is TherapeuticsMD Inc stock a falling knife or bargain buyGap Down & Weekly High Return Stock Opportunities - baoquankhu1.vn
Is TherapeuticsMD Inc forming a double bottomEarnings Trend Report & Reliable Trade Execution Plans - baoquankhu1.vn
Sell Signal: What is the fair value of TherapeuticsMD Inc stock nowMarket Performance Report & Verified Momentum Stock Watchlist - Bộ Nội Vụ
Gains Recap: Why retail investors pile into TherapeuticsMD Inc stockRate Hike & Daily Volume Surge Signals - Bộ Nội Vụ
Institution Moves: How strong is TherapeuticsMD Inc stock revenue growthJuly 2025 Outlook & Reliable Entry Point Alerts - Bộ Nội Vụ
TherapeuticsMD Reports Q3 2025 Financial Results - MSN
Therapeuticsmd Inc (TXMD) 財務データ
収益
当期純利益
現金流量
EPS
1.06%
1.05%
大文字化:
|
ボリューム (24 時間):